Ekspresi Tinggi Androgen Receptor Sebagai Penentu Prognosis Adenokarsinoma Prostat di Sumatera Barat

Anandia Putriyuni, Nurwiyeni Nurwiyeni

Abstract


Abstrak

 Pendahuluan: Adenokarsinoma adalah jenis kanker prostat terbanyak didiagnosis sampai saat ini. Androgen receptor (AR) berperan penting dalam inisiasi, pertumbuhan dan progresifitas adenokarsinoma prostat, tetapi mekanisme AR masih belum jelas. Analisa ekspresi AR sebagai biomarker prognosis adenokarsinoma prostat belum pernah dilakukan di Sumatera Barat.  Tujuan penelitian: Untuk menganalisa ekspresi tinggi AR dalam penentuan prognosis adenokarsinoma prostat di Sumatera Barat. Metode: Rancangan penelitian analitik observasional dengan desain cross sectional. Penelitian dilakukan bulan November 2019 sampai Oktober 2020. Sampel digunakan sebanyak 56 kasus adenokarsinoma prostat secara consecutive sampling yang tersimpan di laboratorium Patologi Anatomik di Sumatera Barat. Slaid yang telah terwarnai hematoxyline dan eosin (HE) dan blok parafin dikumpulkan. Selanjutnya dilakukan review slaid untuk menentukan Gleason score berdasarkan International Society of Urological Pathology (ISUP) 2014/WHO edisi 2016. Metode pewarnaan imunohistokimia (IHK) pada AR untuk menganalisis ekspresi protein secara semikuantitatif. Ekspresi tinggi AR jika interpretasi yang ditemukan strong. Analisis data secara statistik menggunakan uji Chi-square. Hasil: Hasil penelitian mendapatkan kasus adenokarsinoma prostat terbanyak adalah high grade Gleason score (Gleason score 8-10) yaitu 43 (76,79%) kasus dan ekspresi tinggi AR 29 (51,80%) kasus. Adenokarsinoma prostat dengan high grade Gleason score ditemukan ekspresi tinggi AR lebih banyak dibandingkan ekspresi rendah AR. Secara statistik terdapat hubungan yang signifikan antara ekspresi tinggi AR dengan Gleason score (p=0,018). Kesimpulan: Ekspresi tinggi AR merupakan penanda penting untuk progresifitas tumor. Ekspresi AR sebaiknya diperiksa pada kasus adenokarsinoma prostat untuk menentukan prognosis pasien.

Kata kunci -- Adenokarsinoma prostat, Androgen receptor, Gleason score, Prognosis   

 

Abstract

 Introduction: Adenocarcinoma is the most type of prostate cancer diagnosed until now. Androgen receptor (AR) plays important roles in initiation, growth and progression of prostate adenocarcinoma. However, the mechanism of AR is unclear. Analysis of AR expression as the prognostic biomarker in prostate adenocarcinoma has never been done in West Sumatera. Aims: To analyze high AR expression in determining the prognosis of prostate adenocarcinoma in West Sumatera. Method: The observational analytic study was done with cross sectional design. This study was conducted from November 2019 to October 2020. Samples of 56 prostate adenocarcinoma were collected by consecutive sampling stored in Anatomical Pathology Laboratories in West Sumatera. Hematoxylin and eosin (HE) stained slides and paraffin blocks were retrieved. Slides were evaluated to review Gleason score based on the International Society of Urological Pathology (ISUP) 2014/WHO 2016. Immunohistochemistry (IHC) staining method with AR antibody was performed to discover protein expression semiquantitatively. High AR expression was characterized by strong interpretation. Statistical data analysis used Chi-square test. Results: The results showed that the most prostate adenocarcinoma was high grade Gleason score (Gleason score 8-10) in 43 (76.79%) cases and high AR expression in 29 (51.79%) cases. High grade Gleason score of prostate adenocarcinoma showed high AR expression more than low AR expression. There was statistically significant correlation between AR expression and Gleason score (p=0.018). Conclusion: High AR expression is the important marker of tumor progression. We suggest that AR expression should be performed in patients of prostate adenocarcinoma for prognosis.

 

Keywords -- Prostate adenocarcinoma, Androgen receptor, Gleason score, Prognosis  

 


Keywords


ekspresi AR, Gleason score, adenokarsinoma prostat, Sumatera Barat

Full Text:

PDF

References


WHO MONICA Project. MONICA Manual. Part IV: Event registration. Section 2: Stroke event registration data component. WHO [Internet]. 1990 Nov [cited 2016]; Available from: http://www.thl.fi/publications/monica/manual/part4/iv-2.htm, URN:NBN:fi-fe19981155.

World Health Organization. The top 10 causes of death. WHO [Internet]. 2014 May [cited 2016 Apr]; No310. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/.

World Stroke Organization. World stroke campaign. World Stroke Organization [Internet]. 2012 [cited 2016 Apr]; Available from: http://www.world-stroke.org/advocacy/world-stroke-campaign.

Nindela Rini, Junaidi Achmad, Irfanuddin. Profil klinis dan profil rawat inap penderita stroke di Departemen Neurologi RSUP Dr. Mohammad Hoesin Palembang periode 1 Januari 2016-31 Desember 2017. Hipokampus. Vol 1, Suppl 1. 2019. Pp: 10-19.

Zalika Siti. 2016. Gambaran stoke pada rekam medik pasien rawat inap di Rumah Sakit Muhammadiyah Palembang Periode 1 Januari sampai dengan 31 Desember 2014. Skripsi. Fakultas Kedokteran. Universitas Muhammadiyah Palembang: Palembang.

Sutherland G.R, Auer R.N. Primary intracerebral hemorrhage. J Clin Neurosci. 13. 2006. pp: 511-7.

Albers GW, Amarenco P, Easton J.D, Sacco R.L, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. American College Of Chest Physicians Evidence-Based Clinical Practice Guideline. 133. 2008. pp:630S-69S.

Morgenstern L.B, Hemphill J.C, Anderson C. Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professional. The American Heart Association/American Stroke Association. 2010.

Mattishent K, Shing Kwok Chun, Ashkir Liban, Pelpola Kelum, Kyaw Myint Phyo, Loke Kong. Prognostic tools for early mortality in hemorrhagic stroke: systematic review and meta-analysis. J Clin Neurol. Vol 11, Suppl 4. 2015. pp: 339-348.

Hanifah D. 2015. Pengaruh volume perdarahan dan skor glasgow coma scale (gcs) saat masuk rumah sakit terhadap kejadian mortalitas pada pasien stroke perdarahan intraserebral di RSUD DR. Soedarso Pontianak. Skripsi. Fakultas Kedokteran. Universitas Tanjungpura: Pontianak.

Arifin I, Kaelan C, Akbar M, Muis A, Tammasse J, Ganda IJ. Mortalitas pasien strok perdarahan intraserebral menggunakan skor intracerebral hemorrhage di Makassar. Universitas Hasanuddin. 2014.

Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH Score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 32. 2001. pp: 891–897.

Hsieh JT,Ang BT,Ng YP,Allen JC,King NKK. Comparison of gender differences in intracerebral hemorrhage in a multi-ethnic asian population. PloS ONE. Vol 11, Suppl 4. 2016. pp: 362-5.

Sunjaya Willy, Kadri Alfansuri, Husada M Surya, Fitri Aida, Saragih Restuti Hidayani. Gambaran intracerebral hemorrhage (ICH) score pada pasien stroke hemoragik yang dirawat inap di RSUP H. Adam Malik Medan. JMS. Vol 52, Suppl 3. 2019. pp: 108-113.

Rost NS, Smith EE, Chang Y, Snider RW, Chanderraj R, Schwab K, et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage: The FUNC score. Stroke. 39. 2008. pp:2304-2309.

Clarke JL, Johnston SC, Farrant M, Bernstein R, Tong D, Hemphill III JC. External validation of the ICH score. Neurocritical Care. 1. 2004. pp: 53-60.

World Health Organization. Life expectancy at birth (years), 2000-2015: Both Sexes: 2015. WHO [Internet]. 2015 [cited 2016 Dec]; Available from: http://gamapserver.who.int/gho/interactive_charts/mbd/life_expectancy/atl as.html.

Epple C, Brainin M, Steiner T. Intracerebral hemorrhage. In: Brainin M, Heiss WD, editor. Textbook of stroke medicine. 2nd ed. Cambridge University Press; 2013. p.188-206.

Koivunen RJ, Satopaa J, Haapaniemi E, Strbian D, Meretoja A, Mustanoja S, et al. Predictors of early mortality in young adults after intracerebral hemorrhage. Stroke. 45. 2014. pp: 2454-2456.

Godoy DA, Pinero G, Napoli MD. Predicting mortality in spontaneous intracerebral hemorrhage can modification to original score improve the prediction? Stroke. 37. 2006. pp:1038-1044.

Panchal HN, Shah MS, Shah DS. Intracerebral hemorrhage score and volume as an independent predictor of mortality in primary intracerebral hemorrhage patients. Indian J Surg. Vol 77, Suppl 2. 2012. pp:302-304.

Cheung Raymond TF, Zou Liang-Yu. Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage. Stroke. 34. 2003. pp:1717-1722.




DOI: https://doi.org/10.33854/heme.v4i1.871

DOI (PDF): https://doi.org/10.33854/heme.v4i1.871.g331

Refbacks

  • There are currently no refbacks.


Creative Commons License   Health and Medical Journal This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.